Recombinant SARS-CoV-2 Nucleocapsid Protein supplied by Elabscience with collaborator-provided technical specifications. Read more ›
SARS-CoV-2 Nucleocapsid is the stated recombinant protein target for this Elabscience product. The listing uses collaborator-supplied specifications to support research-use-only protein selection through ABMIUM.
Protein profile: reactive species/source: SARS-CoV-2; expression system: HEK293 Cells; physical form: Supplied as a 0.2 μm filtered solution of 50mM Tris-HCl, 150mM NaCl, 50mM Arginine, pH7.5; tag: SARS-CoV-2 ,SARS-CoV-2 Nucleocapsid ,Recombinant Proteins; predicted molecular weight: 46.4 kDa.
Quality and formulation: purity: > 90 % as determined by reducing SDS-PAGE.; concentration: Subject to label value..
Functional evidence: activity: Immobilized 2019-nCoV NP Antibody(6G9)-Fc at 5μg/ml(100 μl/well) can bind Recombinant 2019-nCoV Nucleocapsid Protein (Mammalian)-His. The ED<sub>50</sub> of 2019-nCoV Nucleocapsid Protein-His is 0.172 ug/ml.. In the ABMIUM matrix, collaborator-supplied functional evidence is marked C; unsupported application columns remain N.
Sequence coverage: 46.4 kDa.
Database references: UniProt: QHD43423.2 | NCBI Gene: 43740568 | Gene symbol: SARS-CoV-2 Nucleocapsid.
Research Use Only.
| Collaborator | Elabscience |
| Partner model | PKSV030309_500ug |
| Target | SARS-CoV-2 Nucleocapsid |
| Reactivity | SARS-CoV-2 |
| Concentration | Subject to label value. |
| Purity | >90% by SDS-PAGE |
| Shelf life | 6 months |
| Availability | In stock - ships within 2 business days |
| Lead time | 2-3 business days |
| Category | Bioactivity | Binding | Cell-Based | In Vivo | ELISA Capture |
|---|---|---|---|---|---|
| SARS-CoV-2 |
Collaborator meets ABMIUM quality standards and overall product performance standards have been met.
Quality management certification.
Environmental management certification.
Occupational health and safety management certification.
For research applications. Not for diagnostic use.
REACH compliant.
No customer reviews yet.
